Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -74,196 | -184,062 | -166,283 | -107,482 | -64,284 |
| Depreciation Amortization | 347 | 775 | 641 | 411 | 192 |
| Accounts receivable | -7,048 | -20,817 | -17,579 | -18,976 | -261 |
| Other Working Capital | -32,555 | 8,124 | -6,636 | -15,126 | -13,425 |
| Other Operating Activity | 35,652 | 53,823 | 80,159 | 54,751 | 16,767 |
| Operating Cash Flow | $-77,800 | $-142,157 | $-109,698 | $-86,422 | $-61,011 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -38,066 | 18,189 | 28,201 | 20,089 | 14,771 |
| PPE Investments | -406 | -2,385 | -1,277 | -912 | -99 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 1 |
| Investing Cash Flow | $-38,472 | $15,804 | $26,924 | $19,177 | $14,673 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 7,356 | 65,794 | 12,250 | 7,474 | 2,900 |
| Other Financing Activity | 0 | 293,874 | 0 | 0 | 0 |
| Financing Cash Flow | $7,356 | $359,668 | $12,250 | $7,474 | $2,900 |
| Exchange Rate Effect | 40 | 71 | 69 | 85 | N/A |
| Beginning Cash Position | 507,734 | 274,348 | 274,348 | 274,348 | 274,348 |
| End Cash Position | 398,858 | 507,734 | 203,893 | 214,662 | 230,910 |
| Net Cash Flow | $-108,876 | $233,386 | $-70,455 | $-59,686 | $-43,438 |
| Free Cash Flow | |||||
| Operating Cash Flow | -77,800 | -142,157 | -109,698 | -86,422 | -61,011 |
| Capital Expenditure | -406 | -2,385 | -1,277 | -912 | -99 |
| Free Cash Flow | -78,206 | -144,542 | -110,975 | -87,334 | -61,110 |